@article{ea63bd6628aa423ea35de0c6221930f1,
title = "Evolving Treatment Patterns in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer",
abstract = " ML Lankford ; SL Britton ; AD Buettner ; M Scharf ; B Tiscione ; JP Willey ",
author = "Reshma Mahtani",
note = "Abstract. Background: The last several years have seen the approval of multiple targeted agents for use alone or combined with standard endocrine therapies (ET) in the 1st, 2nd, and 3rd line hormone receptor positive (HR+), HER2 negative (HER2-) metastatic breast cancer (MBC) settings.",
year = "2019",
month = feb,
day = "15",
language = "American English",
volume = "79",
journal = "Cancer Research / San Antonio Breast Cancer Symposium",
}